Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Kipimo cha Uchovu wa Saratani (CFS)× | Mfumo wa Tathmini ya Dalili za Edmonton (ESAS)× | |
|---|---|---|
| Nyanja | Uuguzi wa Onkolojia | Uuguzi wa Onkolojia |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 2000 | 1991 |
| Mwanzilishi≠ | Takuo Okuyama | Eduardo Bruera |
| Aina≠ | Patient self-report three-dimensional fatigue scale | Patient self-report multisymptom palliative care scale |
| Chanzo asilia≠ | Okuyama, T., Akechi, T., Kugaya, A., et al. (2000). Development and validation of a cancer fatigue scale: a brief, three-dimensional, disease-specific instrument. J Pain Symptom Manage, 19(1), 5–14. DOI ↗ | Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care, 7(2), 6–9. DOI ↗ |
| Majina mbadala | CFS, Okuyama Fatigue Scale | ESAS, Edmonton Symptom Assessment Scale |
| Zinazohusiana≠ | 5 | 4 |
| Muhtasari≠ | The Cancer Fatigue Scale is a 15-item disease-specific self-report instrument that comprehensively assesses three dimensions of cancer-related fatigue: physical, cognitive, and emotional. Developed by Takuo Okuyama and colleagues at the Japanese Foundation for Cancer Research and published in 2000, the CFS provides a brief yet multidimensional fatigue profile suitable for both clinical practice and research, with particular strength in non-English-speaking populations where it has been extensively validated. | The Edmonton Symptom Assessment System is a rapid, validated 9-item tool that assesses the severity of common symptoms in cancer and palliative care patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite loss, general well-being, and shortness of breath. Developed by Bruera and colleagues at the University of Alberta in 1991, the ESAS has become the standard symptom-screening instrument in oncology clinics, palliative care units, and end-of-life care settings worldwide, enabling efficient symptom prioritization and management escalation. |
| ScholarGateSeti ya data ↗ |
|
|